ARCHIVES

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

This article is from The Cancer Letter archive.

Vol. 06 No. 41 | October 17, 1980

Download PDF Visit The Full Archive

Related Articles

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

September 3, 1976